It is currently Sat Oct 25, 2014 5:45 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Double Vision

First, I want to express again my thanks for answers to questions I have posted here. Regarding two recent ones, I am on my way to getting appointment at UCSF Clinic (I had asked about clinics in US) and I seeing GP tomorrow about pursuing possible celiac/glutein ataxia link.
So here is another. One of symptoms after initial episode was double vision, occuring only during heavy exercise (running). I thought it was clearing up a ...
Read more : Double Vision | Views : 1233 | Replies : 2 | Forum : General Discussion

Toxic agents and MS

The Boston Cure Project has published its work in relation to Toxic Agents (one of the many possible causes it is examining as part of its Cure Map). The following summarises the results of its work in this area: ... agents.pdf

Read more : Toxic agents and MS | Views : 892 | Replies : 0 | Forum : General Discussion


Novartis published first quarter results today. The following info was provided on FTY720:

FTY720 (fingolimod), an oral once-daily treatment for relapsing forms of multiple sclerosis (MS), is currently in Phase III development. Discussions are continuing with the FDA on starting a Phase III study in the US. Data from an extension of a Phase II trial to 18 months presented in April confirmed the substantial efficacy of FTY720 in significantly reducing the relapse rate and ...
Read more : FTY720 | Views : 1573 | Replies : 1 | Forum : Drug Pipeline

IL-4 Expression by Mast Cells

IL-4 Expression By Mast Cells Modifies The Immune Response In Multiple Sclerosis
This Article
Also Appears In
Allergy Multiple Sclerosis

Main Category: Immune System / Vaccines News
Article Date: 23 Apr 2006 - 17:00pm (PDT)

IL-4 is expressed by many types of immune cells and it can act on a variety of other immune as well as non-immune cells to modulate the immune response. This broad range of effects necessitates strict control of IL-4 expression ...
Read more : IL-4 Expression by Mast Cells | Views : 780 | Replies : 0 | Forum : General Discussion

MS and Heat, Why?


This seems like such a "known", yet I cant find any distinctive medically accepted reason for it. ie MS'ers heat intolerance.

What are the current thoughts on this by the medical profession?

I understand the Prokarin / histamine train of thought, but i am guessing this is not the general practice / accepted reason. or is it?

I am guessing there must be some "accepted" rationale behind it considering Ive herd it was the ...
Read more : MS and Heat, Why? | Views : 4385 | Replies : 21 | Forum : General Discussion

First injection over!!

Well, started the Avonex last night and I have to say the injection wasn't as bad as I had anticipated. It didn't hurt at all and was over in a second.

The side effects kicked in about 4 hours later while in bed (had been trying to get to sleep quick in order to miss them but it never happens when you want it to!). Started feeling a little bit achy, then shivery, then absolutely ...
Read more : First injection over!! | Views : 2685 | Replies : 4 | Forum : Avonex

Neurovax presentation

Here is a link to a presentation on the Immune Response Corp's website about their clinical pipeline, including Neurovax. Not sure if there's anything new here, but it was nice to see their timeline for the upcoming phase IIb Neurovax trial.

if that doesn't work, this one might (select the link at the end of the first paragraph):
Read more : Neurovax presentation | Views : 1576 | Replies : 0 | Forum : Drug Pipeline

Transition Therapeutics


I stumbled across Transition Therapeutics (Canadian company). They have the following drug/s? in trial. Not sure if it / they are on your list?


Clinical Development

A Phase II clinical trial is underway in MS patients with data expected in the second half of calendar 2006. A Phase I clinical trial has demonstrated that EMZ701 is well-tolerated and has a good safety profile.

Creating Best-In-Class Multiple Sclerosis Product

Transition is developing MS-I.E.T. (a ...
Read more : Transition Therapeutics | Views : 1321 | Replies : 1 | Forum : Drug Pipeline

My removed my post

I removed my post
Read more : My removed my post | Views : 1206 | Replies : 2 | Forum : General Discussion

FDA Rejects Medical Marijuana

Hi all

Just saw an article in the Washington Post FDA Rejects Medical Marijuana

WASHINGTON -- The Food and Drug Administration said Thursday that it does not support the use of marijuana for medical purposes....

contradicts a 1999 finding from the Institute of Medicine, part of the National Academy of Sciences, which reported that "marijuana's active components are potentially effective in treating pain, nausea, the anorexia of AIDS wasting and other symptoms, and should be ...
Read more : FDA Rejects Medical Marijuana | Views : 1112 | Replies : 3 | Forum : General Discussion


Login  •  Register


Total posts 220860 • Total topics 22892 • Total members 14455

Contact us | Terms of Service